Why GlaxoSmithKline plc, Telecom plus PLC and Kentz Corporation Limited Should Beat The FTSE 100 Today

GlaxoSmithKline plc (LON: GSK), Telecom plus PLC (LON: TEP) and Kentz Corporation Limited (LON: KENZ) move up on a dull day.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 (FTSEINDICES: ^FTSE) ended yesterday with a 25-point loss, and it’s started today with a further dip of 16 points to 6,682 after ITV shares were downgraded following on from yesterday’s third-quarter update. But the index of top UK shares is only down 11 points on the week so far, and has gained 13% since the start of 2013 — could we be in for a late December surge to push us closer to that record 6,876 level from May?

There’s very little news of individual shares today, but here are three from the various indices that look set to beat the FTSE:

GlaxoSmithKline

Shares in GlaxoSmithKline (LSE: GSK) (NYSE:GSK.US) picked up 9.3p (0.6%) in early trading — not a big rise, but still welcome on a day when the FTSE is falling.

The news today is that the pharmaceuticals giant has completed the sale of part of its stake in Aspen Pharmacare Holdings, having agreed the sale of 28.2 million shares at a price of 250 rand per share. Following the sale, which will net about £425m, Glaxo will sill hold 56.5 million Aspen shares, or 12.4% of the company.

Glaxo shares have been erratic since the Spring, but they’re up around 22% over the past 12 months.

Telecom plus

We need to look outside the FTSE 100 for bigger rises today, and we see Telecom plus shares up a very nice 226p (15%) to 1,733p after the multi-utilities supplier released interim figures and announced an acquisition and share placing.

First-half revenue climbed 17% to £245.8m, with pre-tax profit up 10.1% to £13.7m. Adjusted earnings per share gained 11.5% to 15.5p, and the interim dividend was lifted 23% to 16p per share. These nice figures were made possible by a rise in customer numbers of 33,908, to 494,940.

Telecom Plus has also conditionally agreed to acquire Electricity Plus Supply and Gas Plus Supply from Npower, for a total price of £218m. The deal will be funded by a combination of a new share issue and £100m of borrowing, and will get Telecom plus a 20-year energy-supply deal.

Kentz Corporation

Our third riser for today is Kentz Corporation (LSE: KENZ), whose shares put on 16p (2.9%) to 558p after the company announced a $190m engineering contract with Qatar Petroleum for well-head control systems and corrosion protection for approximately 775 wells in the Dukhan Oilfield in Qatar.

Kentz shares have climbed strongly since the summer, and are now 47% ahead over the past 12 months.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Alan does not own any shares mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Articles

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

This FTSE 250 stock looks great value on a P/E ratio of 8.8

This FTSE 250 industrial company’s been generating big returns for investors lately. But its shares still look very cheap today.

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

This bargain growth stock could be ready for a bull run

Our writer reckons this FTSE 100 growth stock has the potential to deliver stunning returns, but its investors need a…

Read more »

Investing Articles

£25k in savings? Here’s how I’d try and turn that into passive income worth £12k a year

By investing in UK and US shares at knockdown prices I hope to generate a five-figure passive income stream before…

Read more »

Investing Articles

Down 88%, this volatile FTSE 250 stock could be the bargain of the decade!

Dr James Fox believes this FTSE 250 stock could be vastly overlooked, and brokerages agree with him. The average target…

Read more »

Senior woman potting plant in garden at home
Top Stocks

4 robotics stocks Fools think could deliver explosive growth

These stocks are appealing for their growth potential, given the increasing adoption of robotics across various industries.

Read more »

A senior group of friends enjoying rowing on the River Derwent
Investing Articles

How much do I need to invest in UK shares to retire on the passive income they earn?

Investing in a diversified portfolio of dividend stocks can generate a nice passive income to help long-term investors to retire…

Read more »

Investing Articles

Forget the next 5 years, I think these UK dividend shares can last forever

Not much lasts forever. But Stephen Wright thinks some UK firms have advantages that mean their shares can be good…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Micro-Cap Shares

2 exciting penny stocks under 20p to consider buying today

Penny stocks aren’t for everyone. But for those comfortable with risk, they can be worth considering as returns can be…

Read more »